EX-FILING FEES 6 d367482dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

CTI BioPharma Corp.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
     Security Type   Security
Class Title
  Fee
Calculation
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Share
  Maximum
Aggregate
Offering Price
  Fee Rate   Amount of
Registration
Fee
                 
Fees to Be Paid   Equity   Common Stock, $0.001 par value per share   457(o)            
                 
    Equity   Preferred Stock, $0.001 par value per share   457(o)            
                 
    Debt   Debt Securities   457(o)            
                 
    Other   Warrants   457(o)            
                 
    Other   Units   457(o)            
                 
    Unallocated (Universal) Shelf     457(o)   (1)(2)   (3)   $200,000,000  

$92.70 per

$1,000,000

  $18,540(4)
                 

Fees Previously

Paid

                 
           
    Total Offering Amounts     $200,000,000     $18,540
           
    Total Fees Previously Paid        
           
    Total Fee Offsets         $10,255(5)
           
    Net Fee Due               $8,285
(1)

This registration statement registers such indeterminate number of shares of common stock and preferred stock, such indeterminate principal amount of debt securities, such indeterminate number of warrants to purchase common stock, preferred stock and/or debt securities of one or more series, such indeterminate number of rights to purchase common stock, preferred stock and/or debt securities of one or more series, and such indeterminate number of units representing an interest in one or more shares of common stock or preferred stock, debt securities, warrants and/or rights in any combination as shall have an aggregate initial offering price not to exceed $200,000,000. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder.

(2)

Includes rights to acquire common stock or preferred stock of the Company under any shareholder rights plan then in effect, if applicable under the terms of any such plan.

(3)

Estimated solely for the purpose of calculating the registration fee. No separate consideration will be received for shares of common stock that are issued upon conversion of debt securities or preferred stock or upon exercise of common stock warrants registered hereunder. The aggregate maximum offering price of all securities issued pursuant to this registration statement will not exceed $200,000,000.

(4)

The registration fee has been calculated in accordance with Rule 457(o) under the Securities Act of 1933, as amended.


(5)

Pursuant to Rule 457(p), the registrant hereby offsets the registration fee required in connection with this filing by $10,255, which represents a portion of the registration fee previously paid by the registrant with respect to certain unsold securities previously registered on a registration statement on Form S-1 (Registration No. 333-251161) (the “Prior Registration Statement”), initially filed with the Securities and Exchange Commission on December 7, 2020.